Full-Time
Senior Engineering Manager
Provider & Employer Products
Posted on 10/31/2025
Big Health
51-200 employees
Digitally delivers non-drug mental health treatments
Compensation Overview
$200k - $250k/yr
Remote in USA
Remote
 Engineering Management (2) |
|---|
| , |
- 6+ years of engineering management experience with a track record of building and leading high-performing teams
- Proven experience managing remote and distributed engineering teams
- Strong coaching and mentoring skills with experience developing engineers at different career stages
- Experience working in dynamic startup environments with rapid growth and changing priorities
- Deep understanding of full-stack development and modern web architectures
- Hands-on experience with healthcare product development and understanding of healthcare workflows, especially around Ordering and Observations
- Knowledge of healthcare integration standards, including FHIR, HL7, and related protocols and message types, including ORUs, ORMs, ServiceRequest, DeviceRequest, DeviceResponse, Observation, etc.
- Experience with EMRs, such as Epic, Cerner, eCW, Athena, etc.
- Understanding of healthcare data concepts such as orders, claims, eligibility, and patient records
- Experience with healthcare compliance requirements (HIPAA, SOC2, etc.)
- Experience leveraging AI-powered development tools such as v0.dev, Claude AI, ChatGPT, Cursor, and similar platforms
- Familiarity with low-code/no-code platforms and automation tools like n8n
- Platforms and Technologies: Vercel for deployment and hosting, Supabase for backend-as-a-service and authentication, Django & Python for core API application development, Node JS, React, TailwindCSS, ShadCN, Kong, Svix, AWS cloud infrastructure and services, PostgreSQL, GitHub for version control and CI/CD
- Experience with healthcare data standards and APIs
- Knowledge of regulatory compliance in healthcare technology
- Background in agile development methodologies
- Experience with monitoring, logging, and observability tools
- Lead and mentor a globally distributed engineering team (onshore and offshore), fostering a culture of ownership, high quality, and continuous improvement
- Manage team performance, career development, and growth opportunities for engineers at all levels
- Drive technical excellence while maintaining team velocity and morale in a remote-first environment
- Facilitate effective communication and collaboration across time zones and cultural differences to keep the team aligned and productive
- Partner closely with product management to define technical roadmaps and prioritize feature development
- Ensure successful delivery of healthcare solutions for providers and employers, from conception to production
- Drive architectural decisions that support scalability, security, and healthcare compliance requirements
- Drive the adoption and integration of AI-powered development tools and low-code/no-code solutions to enhance team productivity
- Oversee full-stack development across web and mobile platforms, ensuring robust and scalable architectures
- Guide implementation of healthcare integrations and interoperability standards
- Establish and maintain engineering best practices, code quality standards, and testing protocols
- Stay current with emerging technologies and evaluate their potential impact on our products and processes
- Work closely with product, design, and clinical teams to translate requirements into technical solutions
- Collaborate with other engineering managers to ensure consistency and knowledge sharing across teams
- Participate in technical and strategic planning sessions with senior leadership
- Experience with remote-scale engineering leadership in healthcare
- Experience building AI-enabled productivity tools for software teams
- Experience with healthcare security and privacy risk assessments
- Bachelor's degree in Computer Science, Electrical Engineering, or related field (or equivalent practical experience)
- Master's degree in Computer Science, Electrical Engineering, or related field (or equivalent practical experience)
- Experience with HIPAA risk assessment and mitigation processes
- Experience with healthcare data interoperability standards beyond those listed
- Certification in project management or agile frameworks (e.g., PMP, PMI-ACP, or CSM/CSPO)
- Experience managing budgets and headcount planning
- Experience with supplier/vendor management
Big Health provides digital therapeutics for mental health, focusing on non-drug treatments for insomnia, anxiety, and depression. Its products—Daylight, Sleepio, and Spark Direct—offer tailored, evidence-based programs delivered through digital platforms, with real-world effectiveness and minimal side effects. The company also runs a medication assessment program that offers non-drug options and can be added to coverage quickly through pharmacy benefit managers, aided by strong pharmacy integrations for billing. Big Health differentiates itself with a robust evidence base, including over 90 peer‑reviewed publications and 18 randomized controlled trials, and by partnering with employers and health plans to expand accessible care. The overall goal is to provide scalable, effective mental health care that is easy to access and implement through existing healthcare and employer networks.
Company Size
51-200
Company Stage
Late Stage VC
Total Funding
$152.8M
Headquarters
San Francisco, California
Founded
2010
Simplify's Take
What believers are saying
- Raised $23.7M in February 2026 to scale via CMS G-codes G0552-G0554.
- Partnered with Grow Therapy on March 21, 2024, for claims-based billing.
- Sleepio achieves 76% insomnia improvement and 71% anxiety remission.
What critics are saying
- Pear Therapeutics bankruptcy enables Akili to undercut SleepioRx pricing within 6-12 months.
- Calm and Headspace launch FDA-cleared rivals by mid-2026, dominating employer contracts.
- CMS G-codes face reversal under audits, slashing Medicare revenue in 18-24 months.
What makes Big Health unique
- FDA-cleared SleepioRx and DaylightRx treat insomnia and anxiety without drugs.
- Over 90 peer-reviewed publications with 28,000 participants validate efficacy.
- Acquired Limbix in July 2023 to add SparkRx for adolescent depression.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health care - We provide 100% employee coverage for medical, vision, and dental. Plus, free access to Sleepio for poor sleep, Daylight for worry and anxiety, and additional mental health benefits.
Time off - We take balance seriously. Employees get 20 days of PTO plus eight holidays, a year-end week off, and Flex Fridays. Employees also receive 10 days of paid sick leave per year.
Professional development - Employees receive a $1k USD or £800 stipend — plus five paid days off — for professional development, plus a stipend for their work-from-home setup.
Retirement savings - US Employees are eligible to participate in a 401(k) program with company match, and UK employees receive a pension program with NEST.
Team building - Apart, but never alone. We host an annual Summit in-person at our SF HQ (virtual when needed), and regular social events to keep bonds strong.
Family - Employees are eligible for parental leave on day one. Dependents are eligible for 50% coverage on our medical, vision and dental plans, plus access to Sleepio and Daylight.
Growth & Insights and Company News
6 month growth
↓ -1%1 year growth
↓ -1%2 year growth
↑ 0%$23.7M secured to scale fda-cleared digital sleep, anxiety treatments. Following the establishment of new CMS reimbursement codes for digital mental health treatments, the funding will support the commercial expansion of two prescription products. Key takeaways: * Big Health raised $23.7 million in a round co-led by .406 Ventures and AlleyCorp to accelerate access to its prescription digital therapeutics. * The funding follows the introduction of G-codes in the 2025 Physician Fee Schedule, allowing Medicare reimbursement for FDA-cleared Digital Mental Health Treatments. * SleepioRx for insomnia and DaylightRx for generalized anxiety disorder are among nine FDA-cleared treatments in this new category. * The capital will be used to expand provider partnerships and integrate the therapeutics into clinical workflows. Big Health has completed a strategic funding round of $23.7 million to accelerate the adoption of its US Food and Drug Administration (FDA)-cleared digital therapeutics: SleepioRx for insomnia disorder and DaylightRx for generalized anxiety disorder. The funding comes as the Centers for Medicare & Medicaid Services (CMS) implements a new payment policy for digital mental health treatments. The 2025 Physician Fee Schedule created specific G-codes that enable national Medicare coverage for FDA-cleared digital mental health treatments. SleepioRx and DaylightRx are among nine treatments currently recognized in this category, which distinguishes FDA-cleared medical devices from non-regulated wellness apps. CMS adopted three codes, G0552-G0554, for digital mental health treatment devices furnished under a behavioral health treatment plan of care. It also adopted six HCPCS codes that parallel the existing CPT codes for interprofessional consultations for use by certain nonphysician mental health professionals who CMS says cannot report the CPT codes with the goal of better integrating behavioral health treatment into primary care and other settings. "For the first time, providers can offer proven, safe, and effective digital treatments that deliver measurable, reproducible outcomes, and receive reimbursement just as they would for traditional treatments," says Yael Berman, CEO of Big Health, in a release. "We're already seeing the most innovative health systems seize this opportunity, and this funding will help us scale access to these treatments faster." The financing was co-led by .406 Ventures and AlleyCorp, with participation from CVS Health Ventures, Blue Venture Fund, Sandbox Clinical Ventures, Gilde Healthcare, and Supermoon Capital. The funds are earmarked to support commercialization efforts, including expanding strategic provider partnerships and integrating the digital therapeutics into clinical workflows. SleepioRx and DaylightRx are prescription digital therapeutics designed for use alongside usual care. To date, Big Health reports supporting more than 750,000 individuals. Clinical studies cited by the company show that up to 76% of SleepioRx patients achieve improvement in insomnia, while 71% of DaylightRx patients experience improvement in anxiety disorder Investors noted the significance of the new reimbursement landscape for digital health. "We are thrilled to be investing in the Big Health team as they unlock the potential created by CMS's wise decision to reimburse for FDA-cleared digital treatments targeting conditions where such an intervention is proven to be appropriate, superior to current pharmaceutical-only approaches, and ultimately better value for the system," says Liam Donohue, managing partner at .406 Ventures, in a release. Current adoption partners include health systems such as Henry Ford and Northwell. "There's a significant gap between people who need mental health care and those who can access it," says Alyssa Reisner, executive director and partner at CVS Health Ventures, in a release. "SleepioRx and DaylightRx can help fill that gap - offering first-line, evidence-based treatment for insomnia and anxiety at scale, where and when patients need it most."
Big Health raises $23.7M in new funding. February 12, 2026 Big Health, a San Francisco, CA-based developer of digital treatments for mental health conditions, raised $23.7M in new funding. The round was led by .406 Ventures and AlleyCorp, with participation from CVS Health Ventures, Blue Venture Fund, Sandbox Clinical Ventures, Gilde Healthcare, and Supermoon Capital. The company intends to sue the funds to accelerate access to its FDA-cleared, reimbursable solutions. Led by CEO Yael Berman, Big Health is a digital mental health treatments company that expand access to care, including behavioral medicine by making treatments available both directly to patients and through providers, and by improving adoption for providers, payers, and employers. Its FDA-cleared, reimbursable solutions include SleepioRx for insomnia disorder and DaylightRx for generalized anxiety disorder (GAD). To date, Big Health has supported more than 750,000 individuals, with clinical studies showing that up to 76% of SleepioRx patients achieve improvement in insomnia, and 71% of DaylightRx patients experience improvement in GAD. 12/02/2026
New solution integrates evidence-based digital care programs with best-in-class mental health provider networkSAN FRANCISCO, March 21, 2024 /PRNewswire/ -- Big Health , the leading developer of digital treatments for the most common mental health conditions, has partnered with Grow Therapy ("Grow") to launch a comprehensive mental health platform that will support the full spectrum of mental health care needs. Grow's best-in-class provider network will seamlessly integrate with Big Health's clinically proven digital programs for insomnia, anxiety, and depression. The experience will be integrated into customers' existing benefit ecosystems, and offer care to millions for a fraction of the cost of existing platforms.Despite double-digit growth in investments in this area, the mental health crisis continues to worsen. The collaboration between Big Health and Grow Therapy will provide flexibility and scalability in addressing the exploding demand for mental health care services."Mental health continues to be a top priority for employers and other traditional benefits customers. They are facing enormous financial pressure with rising medical spend and economic headwinds. We are meeting the need for a solution that combines the best clinical care and digital programs in one platform that can be billed up to 100% through claims, with no benefits budget required," said Arun Gupta, Big Health's Executive Chairman & CEO.The new comprehensive mental health platform is built for the challenging market dynamics facing organizations, including utilization-based pricing, claims-based billing, and performance guarantees tied to clinical results
"These new data show how treating sleep issues has health benefits across populations, conditions, and ages—rest helps heal our bodies and brains, and is essential to a healthy mind," Colin A. Espie, PhD, Prof. of Sleep Medicine, University of Oxford; co-founder, Chief Scientific Officer, Big Health Tweet thisEighty-four percent of improvements in anxiety among study participants using Sleepio were due to improvements in sleep.In a separate study among stroke survivors, 71% achieved remission using Sleepio compared to 30% of control participants.Improving sleep is a pathway to reduce anxietyIndividuals with insomnia are three times more likely to develop anxiety than healthy sleepers.[1] Additionally, comorbid insomnia and anxiety are associated with greater severity of both conditions — as well as increased symptoms of depression and poorer physical health.[2]Published in the peer-reviewed Journal of Affective Disorders, researchers found that Sleepio's clinically validated impact on insomnia also significantly reduced participants' anxiety symptoms — 84% of improvements in anxiety were due to improvements in sleep. The largest-ever study examining the effects of a digital therapeutic for insomnia in adults with insomnia and clinically significant anxiety, results also showed that after using Sleepio, participants were two times more likely to no longer have clinically significant anxiety versus those in the control arm."The results of our studies show that digital CBT for insomnia can bring about substantial improvements in sleep, and that leads to a lessening of anxiety and depression," Daniel Freeman, PhD, Professor of Psychology at the University of Oxford and co-author of the paper, said. "Improving sleep likely brings a wide range of benefits in its wake."The impact of sleep on stroke recoveryGlobally, one in four people are estimated to experience stroke during their lifetime, and the disease is the third leading cause of disability and death combined.[3] Following stroke, up to 60% of patients report sleep challenges throughout the recovery period.[3] Sleep issues are associated with poorer post-stroke outcomes[4] and higher rates of comorbidity, including anxiety and depression.[5]The peer-reviewed Journal of Sleep Research published results from the INSPIRES study, a randomized controlled trial (RCT) comprising 84 stroke survivors demonstrating that Sleepio was effective at improving sleep, compared with sleep hygiene control, for at least eight weeks post-intervention. Results also showed that, among participants who had insomnia disorder at baseline, 71% in the Sleepio study arm achieved remission post-intervention compared to 30% of control participants
Big Health partners with the American Psychological Association to increase awareness of the value and impact of digital treatments in clinical care delivery.